Clinical Trials Logo

Filter by:
NCT ID: NCT02760602 Terminated - Alzheimer's Disease Clinical Trials

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

ExpeditionPRO
Start date: June 2016
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to investigate the safety and efficacy of the study drug solanezumab in participants with prodromal Alzheimer's disease (AD).

NCT ID: NCT02760329 Completed - Asthma Clinical Trials

Observational Study of Obstructive Lung Disease (NOVELTY)

NOVELTY
Start date: July 25, 2016
Phase:
Study type: Observational

The NOVEL Observational longiTudinal studY (NOVELTY) is an observational study of obstructive lung disease and is a multi-country, multi-centre, prospective, longitudinal cohort study which will recruit patients with a diagnosis, or suspected diagnosis, of asthma and/or Chronic Obstructive Pulmonary Disease (COPD). Patients will undergo clinical assessments and receive standard medical care as determined by their treating physician. Patients enrolled in NOVELTY will be followed up yearly by their treating physician for a total duration of three years. In addition, patients will be followed up remotely every 3 months. The NOVELTY study will collect data currently lacking to allow for multinational data collection to fill regional/local gaps and improve comparability across regions.

NCT ID: NCT02760277 Completed - Clinical trials for Duchenne Muscular Dystrophy

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Start date: July 28, 2016
Phase: Phase 2
Study type: Interventional

The main purposes of this study are to see if it is safe to use a new medication called vamorolone for more than two weeks in children with Duchenne muscular dystrophy (DMD), to see if vamorolone works for the treatment for DMD, and to see how any potential side effects compare to those seen in boys using steroids.

NCT ID: NCT02760264 Completed - Clinical trials for Duchenne Muscular Dystrophy

A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Start date: June 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a new medication called vamorolone is safe and well-tolerated by boys with Duchenne muscular dystrophy (DMD) ages ≥ 4 and < 7 years old.

NCT ID: NCT02759965 Completed - Surgery Clinical Trials

Neuroinflammation and Cognitive Dysfunction After Orthopedic Surgery

Start date: September 1, 2014
Phase:
Study type: Observational

The primary hypothesis that orthopaedic surgery induces a neuroinflammatory response within 48 hours after elective hip or knee surgery and that there is an association between exaggerated CNS inflammatory response or impaired inflammatory resolution and postoperative cognitive dysfunction within one week and at three months postoperatively.

NCT ID: NCT02759380 Recruiting - Prostate Cancer Clinical Trials

Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?

PRODICA
Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if a diet with a high content of phytoestrogens can slow down the prostate tumor proliferation. Phytoestrogens are found in food items such as soy, rye, and seeds. Two hundred thirty men with prostate cancer will be included in the study and followed until surgery (at least 6 weeks). Half of the study participants will receive general information about healthy food choices and a package of foods with high content of phytoestrogens to add to their food. The other half will get the same information but not receive the food-package.

NCT ID: NCT02757235 Completed - Clinical trials for Chronic Subdural Hematoma

The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma

SIC!
Start date: March 2016
Phase: N/A
Study type: Interventional

The study will be a multicenter randomised controlled trial of the use of irrigation fluid of body temperature versus irrigation fluid of room temperature during burr hole evacuation of chronic subdural hematoma.

NCT ID: NCT02756611 Completed - Clinical trials for Chronic Lymphocytic Leukemia

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

VENICE I
Start date: June 22, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of venetoclax monotherapy in participants with relapsed/refractory CLL with or without the 17p deletion or TP53 mutation, including those who have received prior treatment with a B-cell receptor inhibitor.

NCT ID: NCT02756351 Completed - Clinical trials for Pneumonia, Ventilator-Associated

A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization

Start date: April 2016
Phase: N/A
Study type: Interventional

The study is a first step in establishing the safety and efficacy of the CytaCoat technology when applied to a medical device such as a nasal prong and the clinical data generated will serve as a basis for continuous studies in clinically significant settings such as the neonatal care units.

NCT ID: NCT02754817 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Start date: April 26, 2016
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of the study is to investigate the effectiveness of Xultophy® (insulin degludec/liraglutide) in an adult real-world population with type 2 diabetes mellitus.